NASDAQ:AUPH
Investing in Aurinia Pharmaceuticals Inc (AUPH): What You Must Know
Aurinia Pharmaceuticals Inc’s recently made public that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug ...
Analysts review Aurinia Pharmaceuticals Inc’s rating
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug ...
Checking in on Aurinia Pharmaceuticals Inc (AUPH) after recent insiders movement
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug ...
Investing in Aurinia Pharmaceuticals Inc (AUPH): What You Must Know
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug ...
Investing in Aurinia Pharmaceuticals Inc (AUPH): What You Must Know
Aurinia Pharmaceuticals Inc’s filing revealed that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug 01 ...
Understanding the Risks of Investing in Aurinia Pharmaceuticals Inc (AUPH)
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug ...
